中文字幕一二三区,亚洲国产片在线观看,国产网站午夜性色,亚洲国产综合精品2022

<menuitem id="ct2o2"><var id="ct2o2"></var></menuitem>
      1. <noscript id="ct2o2"><progress id="ct2o2"><i id="ct2o2"></i></progress></noscript>
        1. 首頁(yè) > SCI期刊 > SCIE期刊 > JCRQ2 > 期刊介紹

          Journal Of Frailty & Aging

          評(píng)價(jià)信息:

          影響因子:3.3

          年發(fā)文量:32

          衰弱與衰老雜志 SCIE

          Journal Of Frailty & Aging

          《衰弱與衰老雜志》(Journal Of Frailty & Aging)是一本以GERIATRICS & GERONTOLOGY綜合研究為特色的國(guó)際期刊。該刊由Serdi Publishing Company出版商刊期4 issues per year。該刊已被國(guó)際重要權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。期刊聚焦GERIATRICS & GERONTOLOGY領(lǐng)域的重點(diǎn)研究和前沿進(jìn)展,及時(shí)刊載和報(bào)道該領(lǐng)域的研究成果,致力于成為該領(lǐng)域同行進(jìn)行快速學(xué)術(shù)交流的信息窗口與平臺(tái)。該刊2023年影響因子為3.3。CiteScore指數(shù)值為5.9。

          投稿咨詢(xún) 加急發(fā)表

          期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間:

          the Journal Of Frailty & Aging Is A Peer-reviewed International Journal Aimed At Presenting Articles That Are Related To Research In The Area Of Aging And Age-related (sub)clinical Conditions. In Particular, The Journal Publishes High-quality Papers Describing And Discussing Social, Biological, And Clinical Features Underlying The Onset And Development Of Frailty In Older Persons.          The Journal Of Frailty & Aging Is Composed By Five Different Sections: - biology Of Frailty And Aging In This Section, The Journal Presents Reports From Preclinical Studies And Experiences Focused At Identifying, Describing, And Understanding The Subclinical Pathophysiological Mechanisms At The Basis Of Frailty And Aging. - physical Frailty And Age-related Body Composition Modifications Studies Exploring The Physical And Functional Components Of Frailty Are Contained In This Section. Moreover, Since Body Composition Plays A Major Role In Determining Physical Frailty And, At The Same Time, Represents The Most Evident Feature Of The Aging Process, Special Attention Is Given To Studies Focused On Sarcopenia And Obesity At Older Age. - neurosciences Of Frailty And Aging The Section Presents Results From Studies Exploring The Cognitive And Neurological Aspects Of Frailty And Age-related Conditions. In Particular, Papers On Neurodegenerative Conditions Of Advanced Age Are Welcomed. - frailty And Aging In Clinical Practice And Public Health This Journal’s Section Is Devoted At Presenting Studies On Clinical Issues Of Frailty And Age-related Conditions. This Multidisciplinary Section Particularly Welcomes Reports From Clinicians Coming From Different Backgrounds And Specialties Dealing With The Heterogeneous Clinical Manifestations Of Advanced Age. Moreover, This Part Of The Journal Also Contains Reports On Frailty- And Age-related Social And Public Health Issues. - clinical Trials And Therapeutics This Final Section Contains All The Manuscripts Presenting Data On (pharmacological And Non-pharmacological) Interventions Aimed At Preventing, Delaying, Or Treating Frailty And Age-related Conditions.the Journal Of Frailty & Aging Is A Quarterly Publication Of Original Papers, Review Articles, Case Reports, Controversies, Letters To The Editor, And Book Reviews. Manuscripts Will Be Evaluated By The Editorial Staff And, If Suitable, By Expert Reviewers Assigned By The Editors. The Journal Particularly Welcomes Papers By Researchers From Different Backgrounds And Specialities Who May Want To Share Their Views And Experiences On The Common Themes Of Frailty And Aging.the Abstracting And Indexing Of The Journal Of Frailty & Aging Is Covered By Medline (approval By The National Library Of Medicine In February 2016).

          《虛弱與衰老雜志》是一本同行評(píng)審的國(guó)際期刊,旨在發(fā)表與衰老和與年齡相關(guān)的(亞)臨床狀況領(lǐng)域的研究相關(guān)的文章。特別是,該期刊發(fā)表高質(zhì)量的論文,描述和討論老年人虛弱發(fā)生和發(fā)展背后的社會(huì)、生物和臨床特征?!短撊跖c衰老雜志》由五個(gè)不同的部分組成:-虛弱與衰老的生物學(xué)在本部分中,該期刊介紹了臨床前研究和經(jīng)驗(yàn)報(bào)告,重點(diǎn)是識(shí)別、描述和理解虛弱與衰老基礎(chǔ)上的亞臨床病理生理機(jī)制。-身體虛弱和與年齡相關(guān)的身體成分改變研究,探索虛弱的身體和功能成分。此外,由于身體成分在決定身體虛弱方面起著重要作用,同時(shí)也代表了衰老過(guò)程最明顯的特征,因此特別關(guān)注老年肌肉減少癥和肥胖癥的研究。-虛弱和衰老的神經(jīng)科學(xué)本節(jié)介紹了探索虛弱和與年齡相關(guān)疾病的認(rèn)知和神經(jīng)學(xué)方面的研究結(jié)果。特別是歡迎有關(guān)高齡神經(jīng)退行性疾病的論文。-臨床實(shí)踐和公共衛(wèi)生中的虛弱和衰老本期刊的章節(jié)致力于介紹有關(guān)虛弱和與年齡相關(guān)疾病的臨床問(wèn)題的研究。這個(gè)多學(xué)科章節(jié)特別歡迎來(lái)自不同背景和專(zhuān)業(yè)的臨床醫(yī)生處理高齡的不同臨床表現(xiàn)的報(bào)告。此外,該期刊的這一部分還包含有關(guān)虛弱和與年齡相關(guān)的社會(huì)和公共衛(wèi)生問(wèn)題的報(bào)告。-臨床試驗(yàn)和治療學(xué)這最后一部分包含所有提供旨在預(yù)防、延緩或治療虛弱和與年齡相關(guān)的疾病的(藥物和非藥物)干預(yù)數(shù)據(jù)的手稿。《虛弱與衰老雜志》是一份季刊,刊登原創(chuàng)論文、評(píng)論文章、病例報(bào)告、爭(zhēng)議、致編輯的信和書(shū)評(píng)。手稿將由編輯人員評(píng)估,如果合適,還將由編輯指派的專(zhuān)家審稿人評(píng)估。該期刊特別歡迎來(lái)自不同背景和專(zhuān)業(yè)的研究人員撰寫(xiě)的論文,他們可能希望分享他們對(duì)虛弱和衰老共同主題的看法和經(jīng)驗(yàn)?!短撊跖c衰老雜志》的摘要和索引由Medline收錄(2016年2月經(jīng)美國(guó)國(guó)家醫(yī)學(xué)圖書(shū)館批準(zhǔn))。

          如果您需要協(xié)助投稿或潤(rùn)稿服務(wù),您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年,熟悉發(fā)表政策,可為您提供一對(duì)一投稿指導(dǎo),避免您在投稿時(shí)頻繁碰壁,節(jié)省您的寶貴時(shí)間,有效提升發(fā)表機(jī)率,確保SCI檢索(檢索不了全額退款)。我們視信譽(yù)為生命,多方面確保文章安全保密,在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。

          JCR分區(qū)(2023-2024年最新版)

          JCR分區(qū)等級(jí):Q2

          按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
          學(xué)科:GERIATRICS & GERONTOLOGY ESCI Q2 35 / 74

          53.4%

          按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
          學(xué)科:GERIATRICS & GERONTOLOGY ESCI Q2 34 / 74

          54.73%

          Gold OA文章占比 研究類(lèi)文章占比 文章自引率
          17.19% 96.88%
          開(kāi)源占比 出版國(guó)人文章占比 OA被引用占比

          名詞解釋?zhuān)?b>JCR分區(qū)在學(xué)術(shù)期刊評(píng)價(jià)、科研成果展示、科研方向引導(dǎo)以及學(xué)術(shù)交流與合作等方面都具有重要的價(jià)值。通過(guò)對(duì)期刊影響因子的精確計(jì)算和細(xì)致劃分,JCR分區(qū)能夠清晰地反映出不同期刊在同一學(xué)科領(lǐng)域內(nèi)的相對(duì)位置,從而幫助科研人員準(zhǔn)確識(shí)別出高質(zhì)量的學(xué)術(shù)期刊。

          CiteScore 指數(shù)(2024年最新版)

          CiteScore SJR SNIP CiteScore 指數(shù)
          5.9 0.89 1.024
          學(xué)科類(lèi)別 分區(qū) 排名 百分位
          大類(lèi):Medicine 小類(lèi):Physiology (medical) Q2 38 / 113

          66%

          大類(lèi):Medicine 小類(lèi):Geriatrics and Gerontology Q2 39 / 116

          66%

          大類(lèi):Medicine 小類(lèi):Aging Q3 22 / 38

          43%

          名詞解釋?zhuān)?b>CiteScore是基于Scopus數(shù)據(jù)庫(kù)的全新期刊評(píng)價(jià)體系。CiteScore 2021 的計(jì)算方式是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。CiteScore基于全球最廣泛的摘要和引文數(shù)據(jù)庫(kù)Scopus,適用于所有連續(xù)出版物,而不僅僅是期刊。目前CiteScore 收錄了超過(guò) 26000 種期刊,比獲得影響因子的期刊多13000種。被各界人士認(rèn)為是影響因子最有力的競(jìng)爭(zhēng)對(duì)手。

          數(shù)據(jù)趨勢(shì)圖

          歷年IF值(影響因子)

          歷年引文指標(biāo)和發(fā)文量

          歷年自引數(shù)據(jù)

          免責(zé)聲明

          若用戶(hù)需要出版服務(wù),請(qǐng)聯(lián)系出版商。